在Revolution Medicines, Inc.- 股票认股权证中开设新头寸的主要持有者包括 月神资本有限公司 .
本页面显示了上一报告期内增持或开仓的上市机构、基金和大股东的股权结构变化绿色行表示新头寸。点击链接图标查看完整的交易历史记录。
升级以解锁高级数据。
| 文件日期 | 来源 | 投资者 | 类型 | 平均价格 (Est) |
股份 | Δ 股份 (%) |
报告 价值 ($1000) |
Δ 价值 (%) |
投资组合配置 (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-09 | 13F | DLK 投资管理有限公司 | 164,477 | 113.61 | 43 | 2,050.00 | ||||
| 2025-08-12 | 13F | 普利股权公司 | 0 | 0 | ||||||
| 2025-07-17 | 13F | 月神资本有限公司 | 450,000 | 118 | ||||||
| 2025-08-14 | 13F | LMR 合伙人律师事务所 | 2,646,023 | 1.51 | 695 | 602.02 |
| US:RVMDW | US$0.22 |
© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.
This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.
